Aspirin Use After Diagnosis Improves Survival in Older Adults with Colon Cancer: A Retrospective Cohort Study

Use of Aspirin postdiagnosis improves survival for colon cancer patients

(2012) E Bastiaannet et al.   BRITISH JOURNAL OF CANCER

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Colorectal Cancer Surgery in Elderly Patients: Presentation, Treatment, and Outcomes

(2011) K M. Devon et al.   DISEASES OF THE COLON & RECTUM

The survival gap between middle-aged and elderly colon cancer patients. Time trends in treatment and survival

(2011) C.B.M. van den Broek et al.   EJSO

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

(2011) John Burn et al.   LANCET

The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial

(2011) Raghib Ali et al.   Trials

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer

(2010) A. E. Coghill et al.   GUT

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

(2010) Farhat V N Din et al.   GUT

Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial

(2010) Rachel S. Midgley et al.   JOURNAL OF CLINICAL ONCOLOGY

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

(2009) A. Greenhough et al.   CARCINOGENESIS

New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System

(2009) Myrthe P.P. van Herk-Sukel et al.   EUROPEAN JOURNAL OF CANCER

Aspirin Use and Survival After Diagnosis of Colorectal Cancer

(2009) Andrew T. Chan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

The role of COX-2 in intestinal inflammation and colorectal cancer

(2009) D Wang et al.   ONCOGENE

Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer

(2008) S. Ogino et al.   CLINICAL CANCER RESEARCH